FGF23 and hypophosphatemia: The decrease in the level of 1,25(OH)2D3, reduction in expression of soluble Klotho, activation of the renin-angiotensin system, increase in sodium retention in the kidneys, increase in inflammatory markers, and hypophosphatemia could be explanations for the effect of FGF23 on the cardiovascular system.